Drug Counterfeiting - Articles and news items

Covectra launches anti-counterfeit barcode labelling system

Covectra launches anti-counterfeit barcode labelling system

Manufacturing & Packaging, Supplier news / 27 March 2017 / Steve Bremer, Managing Editor

Covectra has launched an anti-counterfeit, tamper-evident, barcode labelling system

SMi group logo

A focus on supply chain security and anti-counterfeiting at Pharmaceutical Logistics

Supplier news / 23 March 2017 / Pharmaceutical Logistics

Mundipharma, GS1, GIRP and TAPA release presentations ahead of the 11th annual Pharmaceutical Logistics Conference which returns to London 18th & 19th May 2017…

Gang sentenced for illegal importation and sale of drugs in the UK

Industry news / 14 June 2016 / Victoria White, Digital Content Producer

The gang imported over 1.2 million unlicensed erectile dysfunction tablets and over 141,000 other illegal medicines including diazepam worth over £3.5 million…

The fight against counterfeit medicines

Industry news / 25 April 2016 / Victoria White, Digital Content Producer

New research is providing the foundation to apply criminology theory to preventing the production and sale of counterfeit medicines…

Counterfeit drugs: a global problem

Blog, Z Homepage promo / 24 March 2016 / Victoria White, European Pharmaceutical Review

We’ve created an infographic on counterfeit drugs, highlighting some of the actions taken to counter this global problem…

Systech to host Uniquity Europe global brand protection conference

Systech to host Uniquity Europe global brand protection conference

Supplier news / 8 March 2016 / Systech International

Global brands focus on consumer safety at Amsterdam conference…

Counterfeit medicines and the need for a global approach

Counterfeit medicines and the need for a global approach

Issue 5 2015, Manufacturing & Packaging / 16 October 2015 / David Shore, Pfizer

Counterfeit medicines pose a serious risk to public health around the world. The trade in fake drugs is considerable; according to Pfizer’s own company records, more than 200 million counterfeit doses of Pfizer product have been intercepted since 2004. Meanwhile, the issue of counterfeits has no single or simple solution and cannot be eliminated by any one individual, organisation or government. It is a global problem that needs а global, collaborative approach…

Dave Elder, GlaxoSmithKline and JPAG

The cost of drug counterfeiting

Issue 1 2015 / 10 March 2015 / David Elder, GlaxoSmithKline and JPAG

The World Health Organisation (WHO) in 2010 described counterfeit medicines as those which are “Deliberately and fraudulently mislabelled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products and counterfeit products may include products with the correct ingredients or with the wrong ingredients, without active ingredients, with insufficient active ingredients or with fake packaging.” The WHO also now uses the term ‘spurious/falsely labelled/falsified/counterfeit (SFFC) medicines’. In addition, there is the related phenomenon of sub-standard medicines, classified by the WHO as: “Genuine medicines produced by manufacturers authorised by the National Medicines Regulatory Authority (NMRA), which do not meet quality specifications set for them by national medicines.” Most of these counterfeit/imitation medicines are manufactured in Asia (predominantly India and China) and Latin America, where patents carry little weight, enforcement agencies are lax and there is a cheap, abundant workforce…

Whitepaper: Chemical characterisation of diverse pharmaceutical samples by Confocal Raman Microscopy

Whitepapers / 1 October 2014 / WITec

Confocal Raman Microscopy (CRM) is extremely useful for drug substance design, for patent infringement and counterfeit analysis…


International reports reinforce need to redouble China anti-counterfeiting efforts, says global hologram trade body

Industry news / 15 September 2014 / Issued on behalf of the IHMA by MHW PR Ltd

Millions of fakes pouring into EU, US and Japanese markets…

Whitepaper: Handheld Analyzers for the Screening of Pharmaceutical Counterfeits

Whitepapers / 1 October 2013 / Thermo Scientific

The magnitude of the counterfeit and substandard pharmaceutical problem has recently gained significant public attention due to a number of high profile incidents and greater media focus…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...